Murine monoclonal anti-myelin basic protein (MBP) antibodies inhibit proliferation and cytotoxicity of MBP-specific human T cell clones

1989 ◽  
Vol 24 (1-2) ◽  
pp. 87-94 ◽  
Author(s):  
Zhang Jingwu ◽  
Arthur A. Vandenbark ◽  
Marie Paule Jacobs ◽  
Halina Offner ◽  
Jef C.M. Raus
1995 ◽  
Vol 756 (1 T-Cell Recept) ◽  
pp. 319-320 ◽  
Author(s):  
J. R. RICHERT ◽  
E. D. ROBINSON ◽  
A. H. JOHNSON ◽  
M. L. COHN ◽  
H. F. MCFARLAND ◽  
...  

1987 ◽  
Vol 16 (1) ◽  
pp. 145 ◽  
Author(s):  
John R. Richert ◽  
Cynthia A. Reuben-Burnside ◽  
Gladys E. Deibler ◽  
Marian W. Kies

Neurology ◽  
1995 ◽  
Vol 45 (10) ◽  
pp. 1919-1922 ◽  
Author(s):  
J. R. Richert ◽  
E.D. Robinson ◽  
K. Camphausen ◽  
R. Martin ◽  
R. R. Voskuhl ◽  
...  

1993 ◽  
Vol 90 (23) ◽  
pp. 11049-11053 ◽  
Author(s):  
F Weber ◽  
E Meinl ◽  
K Drexler ◽  
A Czlonkowska ◽  
S Huber ◽  
...  

Herpesvirus saimiri has recently been shown to immortalize human T cells. It was unknown, however, whether Herpesvirus saimiri transformation affects T-cell receptor (TCR) expression and signal transduction. In the present study, we have transformed CD4+ human T-cell clones specific for human myelin basic protein. The transformed T cells were grown in interleukin 2 and divided in the absence of antigen and antigen-presenting cells. They retained the membrane phenotype of activated T cells and secreted the cytokines interferon gamma and lymphotoxin, but interleukin 4 was not detected. Further, the transformed T cells continued to express the original TCR as demonstrated by TCR variable-region-V beta-specific monoclonal antibodies and TCR sequencing. Antigen-specific recognition and signal transduction by the TCR were demonstrated by myelin-basic-protein-induced HLA-DR-restricted secretion of interferon gamma and lymphotoxin and by myelin-basic-protein-specific proliferation. Antigen specificity and reactivity have been maintained for > 1 year after transformation. Transformation with Herpesvirus saimiri now allows the production of virtually unlimited numbers of (auto)antigen-specific T cells expressing functional TCR and a stable membrane phenotype. This technology will facilitate studies of the pathogenesis of putative autoimmune diseases, such as multiple sclerosis, and may be of help in TCR-targeted immunotherapy.


1988 ◽  
Vol 540 (1 Advances in N) ◽  
pp. 345-348 ◽  
Author(s):  
J. R. RICHERT ◽  
C. A. REUBEN-BURNSIDE ◽  
G. E. DEIBLER ◽  
M. W. KIES

1994 ◽  
Vol 179 (1) ◽  
pp. 279-290 ◽  
Author(s):  
K W Wucherpfennig ◽  
A Sette ◽  
S Southwood ◽  
C Oseroff ◽  
M Matsui ◽  
...  

Immunodominant T cell epitopes of myelin basic protein (MBP) may be target antigens for major histocompatibility complex class II-restricted, autoreactive T cells in multiple sclerosis (MS). Since susceptibility to MS is associated with the DR2 haplotype, the binding and presentation of the immunodominant MBP(84-102) peptide by DR2 antigens were examined. The immunodominant MBP(84-102) peptide was found to bind with high affinity to DRB1*1501 and DRB5*0101 molecules of the disease-associated DR2 haplotype. Overlapping but distinct peptide segments were critical for binding to these molecules; hydrophobic residues (Val189 and Phe92) in the MBP(88-95) segment were critical for peptide binding to DRB1*1501 molecules, whereas hydrophobic and charged residues (Phe92, Lys93) in the MBP(89-101/102) sequence contributed to DRB5*0101 binding. The different registers for peptide binding made different peptide side chains available for interaction with the T cell receptor. Although the peptide was bound with high affinity by both DRB1 and DRB5 molecules, only DRB1 (DRB1*1501 and 1602) but not DRB5 molecules served as restriction elements for a panel of T cell clones generated from two MS patients suggesting that the complex of MBP(84-102) and DRB1 molecules is more immunogenic for MBP reactive T cells. The minimal MBP peptide epitope for several T cell clones and the residues important for binding to DRB1*1501 molecules and for T cell stimulation have been defined.


1991 ◽  
Vol 28 (2) ◽  
pp. 280-290 ◽  
Author(s):  
Y. K. Chou ◽  
P. Henderikx ◽  
M. Vainiene ◽  
R. Whitham ◽  
D. Bourdette ◽  
...  

Neurology ◽  
1988 ◽  
Vol 38 (5) ◽  
pp. 739-739 ◽  
Author(s):  
J. R. Richert ◽  
C. A. Reuben-Burnside ◽  
G. E. Deibler ◽  
M. W. Kies

1995 ◽  
Vol 756 (1 T-Cell Recept) ◽  
pp. 317-318 ◽  
Author(s):  
J. R. RICHERT ◽  
E. D. ROBINSON ◽  
K. CAMPHAUSEN ◽  
E. HASTINGS ◽  
R. MARTIN ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document